Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma
- PMID: 15280410
- PMCID: PMC1770375
- DOI: 10.1136/jcp.2003.015784
Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma
Abstract
Aims: To compare intratumorous microvessel density (MVD) and clinicopathological features in two different groups of hepatocellular carcinoma (HCC), namely: hepatitis B virus (HBV) related HCC (B-HCC) and HCV related HCC (C-HCC).
Methods: Fifty consecutive cases each of B-HCC and of C-HCC were studied. Microvessel numbers were assessed by staining for the antigen CD34; in each case, three areas with the highest numbers of microvessels were counted in both the intratumorous and the surrounding non-tumorous tissue; the mean value represented the final MVD.
Results: Patients with B-HCC were significantly younger than those with C-HCC (mean age, 60.1 (SD, 4.1) v 66.4 (4.3) years); no significant differences were seen for sex or Child's class distribution. The tumour diameter was larger in B-HCCs than in C-HCCs (mean, 5.6 (SD, 1.8) v 3.8 (1.8) cm). Tumour microsatellite formation was significantly higher in C-HCCs (12 v 4 cases). No differences were found for histological subtype, degree of differentiation, tumour encapsulation, and vascular invasion. The mean MVD value was significantly higher in tumorous (mean, 54 (SD, 13.8) v 38 (8.9)) and in the surrounding non-tumorous liver tissue (mean, 15 (SD, 4.3) v 7 (3.1)) of C-HCCs.
Conclusions: C-HCCs present as smaller tumours in older patients, with a higher incidence of tumour microsatellite formation and higher MVD values both in the tumorous and the non-tumorous areas, suggesting a link between HCV infection, angiogenesis, and hepatocarcinogenesis.
Figures
Similar articles
-
Microvessel density analysis in patients with viral hepatitis-related hepatocellular carcinoma.J Gastrointest Cancer. 2015 Jun;46(2):104-8. doi: 10.1007/s12029-015-9684-5. J Gastrointest Cancer. 2015. PMID: 25645584
-
The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.J Exp Clin Cancer Res. 1999 Sep;18(3):379-89. J Exp Clin Cancer Res. 1999. PMID: 10606185
-
Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.Int J Oncol. 2004 Apr;24(4):853-60. Int J Oncol. 2004. PMID: 15010822
-
Angiogenic activity of hepatitis B and C viruses.Antivir Chem Chemother. 2012 Jan 17;22(4):159-70. doi: 10.3851/IMP1987. Antivir Chem Chemother. 2012. PMID: 22182803 Review.
-
Non-B, non-C hepatocellular carcinoma (Review).Int J Oncol. 2013 Nov;43(5):1333-42. doi: 10.3892/ijo.2013.2061. Epub 2013 Aug 20. Int J Oncol. 2013. PMID: 23969900 Review.
Cited by
-
Microvessel density and clinicopathologic characteristics in hepatocellular carcinoma with and without cirrhosis.Biomark Insights. 2007 Feb 14;2:59-68. Biomark Insights. 2007. PMID: 19662192 Free PMC article.
-
Superb microvascular imaging technique in depicting vascularity in focal liver lesions: more hypervascular supply patterns were depicted in hepatocellular carcinoma.Cancer Imaging. 2019 Dec 30;19(1):92. doi: 10.1186/s40644-019-0277-6. Cancer Imaging. 2019. PMID: 31888768 Free PMC article.
-
Anti-PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection-Related Advanced Hepatocellular Carcinoma: A Literature Review.Front Immunol. 2020 May 28;11:1037. doi: 10.3389/fimmu.2020.01037. eCollection 2020. Front Immunol. 2020. PMID: 32547550 Free PMC article. Review.
-
Angiogenesis and liver fibrosis.World J Hepatol. 2015 Mar 27;7(3):377-91. doi: 10.4254/wjh.v7.i3.377. World J Hepatol. 2015. PMID: 25848465 Free PMC article. Review.
-
Systemic treatment and targeted therapy in patients with advanced hepatocellular carcinoma.N Am J Med Sci. 2011 Apr;3(4):167-75. doi: 10.4297/najms.2011.3167. N Am J Med Sci. 2011. PMID: 22540086 Free PMC article.
References
-
- Kim CM, Koike K, Saito I, et al. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991;351:317–20. - PubMed
-
- Trevisani F, D’Intino PE, Caraceini P, et al. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients. Cancer 1995;75:2220–32. - PubMed
-
- Salvucci M, Lemoine A, Saffroy R, et al. Microsatellite instability in European hepatocellular carcinoma. Oncogene 1999;18:181–7. - PubMed
-
- Moriya K, Fujie H, Shintani Y, et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998;4:1065–7. - PubMed
-
- Dutta U, Kench J, Byth H, et al. Hepatocellular proliferation and development of hepatocellular carcinoma: a case control study in chronic hepatitis C. Hum Pathol 1998;29:1279–84. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical